Please use this identifier to cite or link to this item: https://hdl.handle.net/10356/100653
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTao, Jiongen
dc.contributor.authorTan, Iain Beehuaten
dc.contributor.authorDeng, Niantaoen
dc.contributor.authorGoh, Liang-Keeen
dc.contributor.authorWang, Hannahen
dc.contributor.authorDas, Kakolien
dc.contributor.authorZhang, Shenlien
dc.contributor.authorLee, Minghuien
dc.contributor.authorWu, Jeanieen
dc.contributor.authorLim, Kiat Honen
dc.contributor.authorLei, Zhengdengen
dc.contributor.authorGoh, Glennen
dc.contributor.authorLim, Qing-Yanen
dc.contributor.authorTan, Angie Lay-Kengen
dc.contributor.authorPoh, Dianne Yu Sinen
dc.contributor.authorRiahi, Sudepen
dc.contributor.authorBell, Sandraen
dc.contributor.authorLinnartz, Ronalden
dc.contributor.authorZhu, Fengen
dc.contributor.authorYeoh, Khay Guanen
dc.contributor.authorToh, Han Chongen
dc.contributor.authorYong, Wei Pengen
dc.contributor.authorCheong, Hyun Cheolen
dc.contributor.authorRha, Sun Youngen
dc.contributor.authorBoussioutas, Alexen
dc.contributor.authorGrabsch, Heikeen
dc.contributor.authorTan, Patricken
dc.contributor.authorShi, Michael M.en
dc.contributor.authorRozen, Steve G.en
dc.date.accessioned2013-10-07T04:03:30Zen
dc.date.accessioned2019-12-06T20:25:56Z-
dc.date.available2013-10-07T04:03:30Zen
dc.date.available2019-12-06T20:25:56Z-
dc.date.copyright2012en
dc.date.issued2012en
dc.identifier.citationDeng, N., Goh, L.-K., Wang, H., Das, K., Tao, J., Tan, I. B., et al. (2012). A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets. Gut, 61(5).en
dc.identifier.urihttps://hdl.handle.net/10356/100653-
dc.description.abstractObjective Gastric cancer is a major gastrointestinal malignancy for which targeted therapies are emerging as treatment options. This study sought to identify the most prevalent molecular targets in gastric cancer and to elucidate systematic patterns of exclusivity and co-occurrence among these targets, through comprehensive genomic analysis of a large panel of gastric cancers. Design Using high-resolution single nucleotide polymorphism arrays, copy number alterations were profiled in a panel of 233 gastric cancers (193 primary tumours, 40 cell lines) and 98 primary matched gastric non-malignant samples. For selected alterations, their impact on gene expression and clinical outcome were evaluated. Results 22 recurrent focal alterations (13 amplifications and nine deletions) were identified. These included both known targets (FGFR2, ERBB2) and also novel genes in gastric cancer (KLF5, GATA6). Receptor tyrosine kinase (RTK)/RAS alterations were found to be frequent in gastric cancer. This study also demonstrates, for the first time, that these alterations occur in a mutually exclusive fashion, with KRAS gene amplifications highlighting a clinically relevant but previously underappreciated gastric cancer subgroup. FGFR2-amplified gastric cancers were also shown to be sensitive to dovitinib, an orally bioavailable FGFR/VEGFR targeting agent, potentially representing a subtype-specific therapy for FGFR2-amplified gastric cancers. Conclusion The study demonstrates the existence of five distinct gastric cancer patient subgroups, defined by the signature genomic alterations FGFR2 (9% of tumours), KRAS (9%), EGFR (8%), ERBB2 (7%) and MET (4%). Collectively, these subgroups suggest that at least 37% of gastric cancer patients may be potentially treatable by RTK/RAS directed therapies.en
dc.language.isoenen
dc.relation.ispartofseriesGuten
dc.subjectDRNTU::Science::Biological sciencesen
dc.titleA comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targetsen
dc.typeJournal Articleen
dc.contributor.schoolSchool of Biological Sciencesen
dc.identifier.doi10.1136/gutjnl-2011-301839en
dc.identifier.pmid22315472-
item.fulltextNo Fulltext-
item.grantfulltextnone-
Appears in Collections:SBS Journal Articles

SCOPUSTM   
Citations 1

534
Updated on Mar 25, 2024

Web of ScienceTM
Citations 1

507
Updated on Oct 24, 2023

Page view(s) 5

1,026
Updated on Mar 27, 2024

Google ScholarTM

Check

Altmetric


Plumx

Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.